Psychedelics Today, Author at PsyNews.com

Home Authors Posts by admin

2168 POSTS 0 COMMENTS

https://psynews.com

Rethinking Drug Education: From D.A.R.E. Scare Tactics to an Evidence-Based Approach

Tracking Legal Psychedelics in the U.S. and Worldwide

Updates from MAPS: Current Initiatives, Psychedelic Science 2024, and Music as...

Developing Esketamine (Spravato) and Lessons for Psychedelic Drug Developers with Jaskaran...

Navigating Psychedelics for Clinicians and Wellness Practitioners: LIVE

What is Holding Space: Guiding Psychedelic Journeys and Creating Ideal Set...

Preserving Psychedelic Legacies: Shulgin Farm and the Shulgin Archive Project

Natural Medicine Advisory Bulletin 10.1: Legislative Update

MindMed’s ‘Total Elimination’ of Psychotherapy in LSD Study Stokes Debate Around...

Women and Psychedelics, Microdosing, and the Challenges of Psychedelic Parenthood

1...232425...217 Page 24 of 217

EDITOR PICKS

Pα+ Psychedelic Bulletin #185: Joe Rogan on Ibogaine; Wisconsin Medicaid to...

Billionaire Investor Antonio Gracias Plots $100M Lykos Takeover with Doblin’s Backing

Can Legalization Serve the Greater Good? The Ethical Challenges of Psychedelic...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin